Jacobson Pharma Corporation Limited

HKEX:2633.HK

0.75 (HKD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q32014 Q22014 Q12013 Q42013 Q3
Operating Activities:
Net Income 136.80573.431114.852136.19297.62780.03971.2102.5187.276127.218097.531121.94180.329122.27657.05284.4761.1425.47625.47643.08943.08943.08943.089
Depreciation & Amortization 70.4271.40391.74992.71195.01597.582102.74988.95280.10685.45058.51152.94356.40646.6232.50837.31930.0513.23613.23610.99910.99910.99910.999
Deferred Income Tax 00-172.96100000000083.64100000000000
Stock Based Compensation 0019.1350000001.50903.8126.2343.50000000000
Change In Working Capital 00-29.6720-21.1610000000-89.8750-93.2950-30.729-0.714-0.714-0.714-4.76-4.76-4.76-4.76
Accounts Receivables 0023.7790-62.7880000000-50.9350-44.480-2.9010000000
Change In Inventory 00-53.451041.6270000000-38.940-48.8150-27.828-1.121-1.121-1.121-4.178-4.178-4.178-4.178
Change In Accounts Payables 0000000000000000-3.2630000000
Other Working Capital 000000000000000000.4070.4070.407-0.582-0.582-0.582-0.582
Other Non Cash Items 10.853292.424313.853267.895.645329.044212.287217.05102.751223.903049.33725.136-13.62-12.20810.5638.6580.5422.442.44-11.76-11.76-11.76-11.76
Operating Cash Flow 218.078294.452336.956311.28198.257311.501180.738230.608109.921265.6710209.191116.379126.61563.393100.12129.71891.73240.43940.43937.56837.56837.56837.568
Investing Activities:
Investments In Property Plant And Equipment -65.471-64.038-49.131-13.873-25.611-38.253-25.005-38.349-39.689-44.7190-167.8537.886-94.739-42.292-50.062-66.521-67.622-84.903-84.903-50.098-50.098-50.098-50.098
Acquisitions Net 00.11311.363-0.888-11.3470-186.217-13.5850.097-107.348000-38.992-801.353000000000
Purchases Of Investments 0-70.205-1.5570-32.667-17.911-38.665-105.376-207.427-52.8500000000000000
Sales Maturities Of Investments -71.567116.0141000.55772.98843.3237.6860000000000000000
Other Investing Activites 0.12470.205-76.202-10.559-1.3910.881-20.4221.209-0.8090.9960-150.146-203.881.32881.3736.1580.1110.30984.90384.90350.09850.09850.09850.098
Investing Cash Flow -136.91452.089-29.325-14.761-70.45917.705-226.986-148.415-247.828-203.9210-317.999-195.994-132.403-762.272-43.904-66.41-67.313-84.903-84.903-50.098-50.098-50.098-50.098
Financing Activities:
Debt Repayment -606.276-182.7210137.861-25.264-258.579-26.228-2.63230.506120.4430-85.053011.9430204.219023.807000000
Common Stock Issued 38.89800000145.25300-1.29500000000007.0017.0017.0017.001
Common Stock Repurchased -7.6850-9.898-22.522000-1.501360.707-511.60200000000000000
Dividends Paid -48.084-45.519-104.0280-51.7230-63.2170-39.967-60.2650-58.453-16.341-25.419-14.525-224.8-1.8-2.407-2.407-2.407-0.45-0.45-0.45-0.45
Other Financing Activities 12.33-182.985-18.317-28.738-9.058-13.264-11.14-19.18-550.099477.2430388.162458.669-14.234373.641580.908-72.465-17.128-85.68593.705-10.40213.608-10.40213.608
Financing Cash Flow -642.03-411.225-132.24386.601-86.045-271.84344.668-23.313-158.88625.8190244.656409.254-27.71359.116560.327-74.2656.679-88.092-88.092-10.852-10.852-10.852-10.852
Other Information:
Effect Of Forex Changes On Cash 0-0.6860.621-1.365-0.17-0.643-477.916-0.825-421.4130.7950-1.1790.7540.1530.076-0.096-0.209-0.012115.434115.43427.0627.0627.0627.06
Net Change In Cash -459.111-165.37176.009381.756-58.41756.720.85461.503-300.21388.3640134.669330.393-33.345-339.687616.447-73.3661.218-17.122-17.1223.6793.6793.6793.679
Cash At End Of Period 411.937871.0481,036.418860.409478.653537.07480.35479.496417.993718.206791.402791.402656.733326.34359.685699.37220.73194.09115.75115.75132.87332.87332.87332.873